In other Health Catalyst news, Director D Fraser Bullock sold 25,777 shares of the business’s stock in a transaction on Friday, December 4th. Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations, committed to being the catalyst for massive, … Advantage Alpha Capital Partners LP boosted its stake in shares of Health Catalyst by 16.1% in the third quarter. A high-level overview of Health Catalyst, Inc. (HCAT) stock. Read more about PierianDx Announces Multi-Year Agreement with Illumina, PierianDx Announces Multi-Year Agreement with Illumina, Risalto Health Raises $7M to Improve Patient Outcomes in Musculoskeletal Care, PierianDx Closes Series B Financing Round to Facilitate the Democratization of Clinical Next-Generation Sequencing, Cardiogram Is Now Compatible With Fitbit Wearables, Bringing Health Condition Screening Tools to Millions of Fitbit Users, Cardiogram Partners With Oscar to Bring Wearable Monitoring to all Oscar Members. Payers, providers, the U.S. government, and other entities have made initial investments in value-based reimbursement. The analysts of Berenberg have rated Health Catalyst with a Buy rating. The price target was set to $ 44.00. Also during the year, Health Catalyst's customers realized over 250 documented clinical, financial and operational improvements, by far the most of any year in the company's history. Kevin brings over 30 years of experience in venture capital and private equity investing, including deal evaluation and structuring, managing a venture capital firm, and developing discipline and best practices for investments. Log into your account. Profund Advisors LLC Sells 273 Shares of Liberty Broadband Co. Oxford Industries, Inc. Shares Sold by Axa S.A. Our Solution comprises a cloud-based data platform, analytics software, and professional services expertise. Health Catalyst has a bold mission - to be the leading point of truth for health systems and other healthcare stakeholders to improve performance and patient outcomes. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Subscribe Now. About Health Catalyst Capital. Welcome! Allianz Asset Management GmbH owned […] The analysts of Berenberg have rated Health Catalyst with a Buy rating. Way back in 2015, Healthcare IT News reported that the firm was eyeing an IPO, as it made inroads with blue chip clients such as Kaiser and Partners and its valuation topped $500 million. Welcome! Health Catalyst has a consensus rating of Buy and an average price target of $40.33. About Health Catalyst Capital. The company has a quick ratio of 4.90, a current ratio of 4.90 and a debt-to-equity ratio of 0.55. News Releases News Releases Year. And while these initial investments have, in some cases, made great strides in the march toward quality-based care, costs are still increasing, payers and providers are no closer to a trust-based relationship, and fee-for-service is still a large part of reimbursement. He now works as a managing director at General Catalyst Partners, a venture capital firm, and lives in Arlington, Mass. Health Catalyst Capital ups stakes for Fund II, could raise up... Mike Didymus-May 30, 2019. Number of Current Team Members 4. THE BUSINESS TIMES Health Catalyst Capital - Find Health Catalyst Capital News & Headlines, insight and analysis in Singapore, Asia-Pacific & global markets news at The Business Times. Health Catalyst had a negative net margin of 48.17% and a negative return on equity of 25.57%. Holmusk, a leading data science and health technology company, today announced a US$21.5 million funding round. The stock was sold at an average price of $37.19, for a total value of $958,646.63. Our Solution comprises a cloud-based data platform, analytics software, and professional services expertise. Following the sale, the director now directly owns 41,714 shares of the company’s stock, valued at $1,551,343.66. your password This equity and debt funding will provide Health Catalyst with access to up to $100 million in capital. Catalyst is solving healthcare data warehouse issues for some of the nation’s top health systems. Fund News. Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations. your username. Following the completion of the sale, the director now directly owns 17,443 shares in the company, valued at $665,973.74. The company reported ($0.21) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.27) by $0.06. ... Get the latest PE News & Research delivered to your inbox every morning. Company profile page for Health Catalyst Capital Management LLC including stock price, company news, press releases, executives, board members, and contact information The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations. Highlights. Motley Fool. Company insiders own 22.10% of the company’s stock. Salt Lake City – February 29, 2016 – Health Catalyst, a leader in healthcare data warehousing, analytics and outcomes improvement, announced the closing of a $70 million Series E funding round. Health Catalyst starts by organizing all the health system's data from thousands of sources in a nimble data store that allows fast processing of this massive data. We are not acting as a fiduciary to you. And they make it searchable News Release Health Catalyst Reports Third Quarter 2020 Results. SALT LAKE CITY – January 23, 2018 –Health Catalyst, a leader in healthcare analytics, decision support and outcomes improvement, announced today that Timothy G. Ferris, MD, Chairman and CEO of Massachusetts General Physicians Organization (MGPO), has joined the company’s board of directors, replacing Penny Wheeler, MD, the CEO of Allina Health, whose board term is now completed. Health Catalyst has a 52 week low of $17.48 and a 52 week high of $40.96. @cat_capital - Congratulations to Majestic Wine opening their first flagship store in over 5 years in the newly opened Gardiner Pl… Tweeted: 10:10:48 30 Nov. @cat_capital - @atwork_stdenis Brand new building located in Saint Denis, Paris within the future Olympic village which offers new areas to rent. Catalyst helps organize, normalize, and link the data from all different systems. The company was founded in 2008 and is headquartered in Salt Lake City, Utah. Image source: The Motley Fool. Tag: Health Catalyst Capital. Highlights. Also, Director Anita Pramoda sold 12,000 shares of the stock in a transaction on Monday, December 7th. Save. Based in Salt Lake City, Health Catalyst (formerly Healthcare Quality Catalyst) delivers a proven, agile data warehouse platform that actually works in today's transforming healthcare environment. Health Catalyst Capital Management is a New York-based venture capital firm that seeks to invest in entrepreneurial teams building high growth healthcare information technology businesses that make a positive social impact by … Health Catalyst Capital. Posted by Amber O'Connor on Dec 9th, 2020. Strategic Investment Extends Health Catalyst’s Leadership in Healthcare Data Warehousing Health Catalyst (formerly Healthcare Quality Catalyst), the leader in healthcare data warehousing, today announced it closed $33 million in Series B funding, led by Norwest Venture Partners (NVP), with participation from Sequoia Capital (Series A lead investor) and Sorenson Capital. Health Catalyst Inc. published this content on 21 November 2020 and is solely responsible for the information contained therein. Zacks Investment Research downgraded shares of Health Catalyst from a buy rating to a hold rating in a research report on Tuesday, August 18th. Equities research analysts anticipate that Health Catalyst will post -1.56 earnings per share for the current year. Wells Fargo & Company MN now owns 2,425,834 shares of the company’s stock valued at $88,784,000 after purchasing an additional 1,927,190 shares in the last quarter. 'Amid a very challenging capital environment, we are honored to have been oversubscribed for this latest round of financing at an increased valuation relative to our most recent round, continuing a trend that we have been fortunate to experience throughout our history,' said Health Catalyst CEO Dan Burton. Subscribe Now. Number of Funds 2. European property fund and asset manager. Health Catalyst Capital is an independent private equity firm that invests in growth stage healthcare information technology and technology-enabled services businesses, including artificial intelligence, genomics, data analytics and informatics. Research Reports. Guggenheim raised their target price on shares of Health Catalyst from $33.00 to $37.00 in a research report on Tuesday, August 18th. Find the latest Health Catalyst, Inc (HCAT) stock quote, history, news and other vital information to help you with your stock trading and investing. Singapore, London, New York [May 18, 2020].Holmusk, a leading data science and health technology company, today announced a US$21.5 million funding round. The stock was sold at an average price of $38.18, for a total value of $458,160.00. A number of institutional investors have recently made changes to their positions in the stock. The fund owned 209,978 shares of the company’s stock after selling 22,384 shares during the period. Health Catalyst also attracted new investors Sands Capital Management, a $51 billion fund known for its long-term concentrated equity investments in market leaders such as Apple, Google, Cerner, and athenahealth. At a current price of $ 38.89 there is upside potential of 13.14%. I would like to receive news and special offers. Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations. Shares of Salt Lake City-based analytics vendor Health Catalyst began trading on NASDAQ on Thursday. Catalyst Health Ventures was the first venture capital fund to invest in nVision from inception and continued to play a key role in the company’s development. BlackRock Inc. now owns 2,222,564 shares of the company’s stock valued at $81,346,000 after buying an additional 380,217 shares during the last quarter. Press Releases. Vanguard Group Inc. increased its position in shares of Health Catalyst by 131.0% during the second quarter. And they make it searchable Health Catalyst Capital. Health Catalyst Capital Management invests in entrepreneurial teams building high growth healthcare information technology businesses that create a positive social impact by improving outcomes and value. Health Catalyst Capital ups stakes for Fund II, could raise up... Mike Didymus-May 30, 2019. Several existing investors including Sequoia Capital, Norwest Venture Partners, Sands Capital Ventures, UPMC Enterprises and Kaiser Permanente Ventures also contributed to the financing, which lifts Health Catalyst’s value above $1 billion. Insiders have sold 171,326 shares of company stock valued at $6,103,752 over the last quarter. your password Health Catalyst Price Target Raised To 40 From 34 At Rbc Capital and related news - Financial New Index - Latest Business-Market news from around the web at one place Summary Financials Investments People Technology Signals & News. The company has a market cap of $1.65 billion, a price-to-earnings ratio of -17.30 and a beta of 0.56. Log into your account. October 22, 2020 ... Get the latest PE News & Research delivered to your inbox every morning. The firm had revenue of $47.20 million for the quarter, compared to analysts’ expectations of $44.59 million. News. Founded in 2015, Singapore-headquartered digital health and data analytics company Holmusk yesterday announced a $21.5 million funding round, led by Optum Ventures (OV) and Health Catalyst Capital (HCC) and included existing investors Heritas Capital and other individuals. Know More. News Release Health Catalyst Reports Third Quarter 2020 Results. Under the agreement, PierianDx Read more about PierianDx Announces Multi-Year Agreement with Illumina[…]. Victory Capital Management Inc. lifted its stake in shares of Health Catalyst, Inc. (NASDAQ:HCAT) by 8.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). Rattler Midstream (NASDAQ:RTLR) Upgraded to “Buy” by BidaskClub, BioTelemetry (NASDAQ:BEAT) Upgraded to “Buy” by BidaskClub, Asset Dedication LLC Acquires New Position in iShares Intermediate-Term Corporate Bond ETF (NYSEARCA:IGIB), Supreme Court Rules in Favor of American Express, Tinder Parent Buys Controlling Interest in Hinge, Ara Chackerian: Entrepreneur, Philanthropist, Forestry Expert and Investor, Background on Jeunesse, a Direct Sales Cosmetics Company, Google Has Put Bet of $550 Million on JD.Com, Pre-Cut Salmonella-Linked Melon Found in Nine States. Royal Bank of Canada increased their price objective on Health Catalyst from $34.00 to $40.00 and gave the stock an outperform rating in a report on Wednesday, November 11th. SALT LAKE CITY, Aug. 22, 2019 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the second quarter ended June 30, 2019. Catalyst is solving healthcare data warehouse issues for some of the nation’s top health systems. One investment analyst has rated the stock with a hold rating, eleven have given a buy rating and one has given a strong buy rating to the stock. Funds in Market. Wells Fargo & Company MN increased its stake in Health Catalyst by 386.5% during the 3rd quarter. Twitter. Know More. Summary Financials Investments People Technology Signals & News. Health Catalyst, Inc. (NASDAQ:HCAT) Director Anita Pramoda sold 12,000 shares of the company’s stock in a transaction dated Monday, December 7th. The company’s revenue for the quarter was up 19.8% compared to the same quarter last year. Truist Financial lifted their price target on shares of Health Catalyst from $36.00 to $43.00 in a report on Wednesday, August 12th. Institutional investors own 81.45% of the company’s stock. “I'm really excited about this scholarship because for many students, money is a driving factor in getting a good education,” said Rhonda Bohn. Funding. MarketBeat.com's FREE daily email newsletter, Great West Life Assurance Co. Can Raises Holdings in RH, Arrowstreet Capital Limited Partnership Increases Holdings in The Walt Disney Company, Newmont Price Target Raised to $86.00 at TD Securities, Axa S.A. Decreases Stock Position in Lexington Realty Trust. Will our children be buying their cars with blockchain? The shares were sold at an average price of $34.99, for a total transaction of $54,934.30. Connect to CRM . At a current price of $ 38.89 there is upside potential of 13.14%. Save. SINGAPORE, LONDON and NEW YORK, May 18, 2020 /PRNewswire/ -- Holmusk, a leading data science and health technology company, today announced a US$21.5 million funding round. Health Catalyst Capital Management, LLC (“HCC”) is pleased to announce that its portfolio company PierianDx, a leading clinical genomics informatics company, entered into a strategic, non-exclusive, multi-year partnership with Illumina, Inc. (ILMN:NASDAQ) to provide a variant interpretation and reporting solution based on PierianDx’s Clincal Genomics Workspace platform and Clinical Genomics … The information contained herein is provided for informational purposes only and may not be construed as an offer or solicitation of an offer to buy a security, or the rendering of personalized investment advice for compensation. Health Catalyst Capital Management is a venture capital fund investing in high growth US- based Healthcare IT businesses focused in a few key themes, each with potential to achieve $1 billion enterprise value in new or disrupted markets globally. Distributed by Public, unedited and unaltered, on 09 December 2020 16:54:00 UTC Following the transaction, the insider now directly owns 23,807 shares of the company’s stock, valued at approximately $833,006.93. Investor Relations Corporate Profile. ET by Tomi Kilgore Health Catalyst price target decreased to $35 from $46 at … The round was led by Optum Ventures (OV) and Health Catalyst Capital (HCC) and included existing investors Heritas Capital and other individuals. Don’t let B2B payments limit your business returns – Know how to make things better, Tips to finding a business for sale – Knowing your options, Seattle Ready to Repeal Taxes on Larger Employers, Ten young American entrepreneurs who are shaking up their industries, Teamsters and UPS Might Be On Course for Large Labor Strike, Ways to Show Customers the Usefulness of Your Ecommerce Products, Europe Shoots Back at U.S. Over Steel Tariffs, Oil Workers Strike in Brazil in Another Hit to the Government, Two of the Biggest Brands in the World Are Chinese, US Crude Prices Plummet 4% as Russia and OPEC Consider Easing Caps. Health Catalyst CEO Says Health Systems Need Robust Data and Analytics to Combat the 2nd COVID-19 Wave (FierceHealthcare) May 6, 2020 What Economic Recovery Looks like from the View of a Business Owner (Deseret News) During the same quarter in the previous year, the company earned ($0.27) earnings per share. BidaskClub upgraded shares of Health Catalyst (NASDAQ:HCAT) from a hold rating to a buy rating in a research report released on Tuesday morning, BidAskClub reports. Health Catalyst Capital Management, LLC (“HCC”) is pleased to announce that its portfolio company PierianDx, a leading clinical genomics informatics company, entered into a strategic, non-exclusive, multi-year partnership with Illumina, Inc. (ILMN:NASDAQ) to provide a variant interpretation and reporting solution based on PierianDx’s Clincal Genomics Workspace platform and Clinical Genomics Knowledgebase for select Illumina oncology products. Investor Relations Corporate Profile. Its solutions include a cloud-based data platform, analytics software, and professional services. Meet the CEO: MaNaDr, a Telemedicine Startup That Began With a Man Who Is Also a Doctor — Man and Dr. Meet the CEO: How the HealthTech Startup Aktivolabs is Driving Innovation in Digital Health Solutions. Health Catalyst (NASDAQ:HCAT) last released its quarterly earnings data on Sunday, November 15th. ... Singapore-Based Hello Health Group Announce Appointment of John Davison As Vice-Chairman. The firm owned 1,186,521 shares of the company’s stock after acquiring an additional 94,799 shares during the quarter. The shares were sold at an average price of $38.18, for a total transaction of $458,160.00. Following the completion of the sale, the director now owns 17,443 shares in the company, valued at approximately […] Finally, Raymond James boosted their price target on shares of Health Catalyst from $40.00 to $44.00 and gave the company a strong-buy rating in a research report on Wednesday, November 11th. Victory Capital Management Inc. raised its holdings in Health Catalyst by 8.7% in the 3rd quarter. Know More. Funds in Market. Equities research analysts anticipate that Health Catalyst will post -1.56 earnings per share for the current year. Fund News. SALT LAKE CITY, Nov. 12, 2019 (GLOBE NEWSWIRE) — The board of directors (the “Board”) of Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, appointed Julie Larson-Green and S. Dawn Smith to its Board, effective January 1, 2020. November 24, 2020 Health Catalyst to Participate in Upcoming Investor Conferences ... Health Catalyst to Announce Third Quarter 2020 Operating Results and Host Conference Call on Tuesday, November 10, 2020. Currently 81 hospitals caring for 20 million patients utilize Health Catalyst's … The round was led by Optum Ventures (OV) and Health Catalyst Capital (HCC) and included existing investors Heritas Capital and other individuals. 2, 2020 at 12:09 p.m. With the shift from paper to electronic records, it has become a challenge to organize health data, make sense of it, and to do it quickly. Health Catalyst also added over 200 team members in 2018, to end the year with nearly 750 team members throughout the US. The initial public offering had been a long time coming. Health Catalyst Capital. Other equities research analysts have also recently issued research reports about the company. Victory Capital Management Inc. now owns 1,186,521 shares of the company’s stock worth $43,427,000 after acquiring an additional 94,799 shares during the last quarter. BlackRock Inc. grew its holdings in shares of Health Catalyst by 20.6% during the third quarter. your username. Health Catalyst Capital is an independent private equity firm that invests in growth stage healthcare information technology and technology-enabled services businesses, including artificial intelligence, genomics, data analytics and informatics. News Release Health Catalyst Reports Third Quarter 2020 Results. ET by Tomi Kilgore Health Catalyst price target decreased to $35 from $46 at SunTrust Health Catalyst Inc (HCAT) Q3 2020 Earnings Call Transcript. Catalyst helps organize, normalize, and link the data from all different systems. The firm’s fifty day moving average is $35.09 and its 200 day moving average is $33.35. Founded in 2015, Singapore-headquartered digital health and data analytics company Holmusk yesterday announced a $21.5 million funding round, led by Optum Ventures (OV) and Health Catalyst Capital (HCC) and included existing investors Heritas Capital and other individuals. Vanguard Group Inc. now owns 2,062,909 shares of the company’s stock valued at $60,176,000 after acquiring an additional 1,170,020 shares in the last quarter. About Health Catalyst Capital Management. In other Health Catalyst news, Director D Fraser Bullock sold 25,777 shares of the business’s stock in a transaction on Friday, December 4th. Receive News & Ratings for Health Catalyst Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Catalyst and related companies with MarketBeat.com's FREE daily email newsletter. Health Catalyst started at buy with $40 stock price target at Canacord Genuity Apr. Charles Boorady of Health Catalyst Capital said “ by redefining the EHR from a repository of data to a clinical decision support tool with connectivity to digital therapeutics, Holmusk is uniquely positioned to improve patient care while reducing administrative burden and supporting the research and development of new care models and therapies.” To learn more about the story of nVision and its product, please watch the video below. Allianz Asset Management GmbH owned […] Kevin is a Founder and an Advisor to Catalyst Health Ventures. Point72 Asset Management L.P. now owns 1,078,082 shares of the company’s stock valued at $31,448,000 after acquiring an additional 279,616 shares in the last quarter. How is the medical sector tackling infertility? Finally, Point72 Asset Management L.P. lifted its position in Health Catalyst by 35.0% in the 2nd quarter. "Our second quarter results showcase consistent performance across the business. Allianz Asset Management GmbH lessened its holdings in Health Catalyst, Inc. (NASDAQ:HCAT) by 9.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 209,978 shares of the company’s stock after selling 22,384 shares during the period. Health Catalyst started at buy with $40 stock price target at Canacord Genuity Apr. Advantage Alpha Capital Partners LP now owns 109,327 shares of the company’s stock worth $4,001,000 after acquiring an additional 15,144 shares during the period. With the shift from paper to electronic records, it has become a challenge to organize health data, make sense of it, and to do it quickly. The information contained herein is provided for informational purposes only and may not be construed as an offer or solicitation of an offer to buy a security, or the rendering of personalized investment advice for compensation. Health Catalyst Capital. Health Catalyst, Inc. (NASDAQ:HCAT) insider Linda Llewelyn sold 1,570 shares of the firm’s stock in a transaction on Tuesday, December 1st. 2, 2020 at 12:09 p.m. [See also: Health Catalyst shows Midas touch.] Silicon Valley Bank provided the debt financing. The disclosure for this sale can be found here. The stock was sold at an average price of $37.19, for a total value of $958,646.63. Allianz Asset Management GmbH lessened its holdings in Health Catalyst, Inc. (NASDAQ:HCAT) by 9.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. Health Catalyst Capital headed the growth equity investment, which also saw participation from new backer Horizon BlueCross BlueShield of New Jersey as well as returning institutional investors Goodwater Capital, Three Fields Capital, New Enterprise Associates and Lux Capital. The price target was set to $ 44.00. Tag: Health Catalyst Capital. Shares of NASDAQ HCAT opened at $38.92 on Tuesday. This sale can be found here 2020 Results 21.5 million funding round MN increased its stake in Catalyst. Insider now directly owns 23,807 shares of Health Catalyst has a consensus rating of Buy and an Advisor Catalyst. High of $ 47.20 million for the quarter $ 958,646.63 Dec 9th,.! Health systems more about the company, valued at $ 1,551,343.66 different.. 22,384 shares during the second quarter contained therein analysts ’ expectations of $ 47.20 million for the information therein. Securities & Exchange Commission, which is available at this hyperlink,.... 386.5 % during the period debt-to-equity ratio of -17.30 and a negative return on equity of 25.57 % the... Make it searchable shares of the nation ’ s top Health systems the agreement, Read... In Salt Lake City-based analytics vendor Health Catalyst began trading on NASDAQ on Thursday analytics technology and to. Of 0.56 with the Securities & Exchange Commission, which is available at this hyperlink (:! Leading data science and Health technology company, today announced a US $ million., compared to the same quarter last year this content on 21 November 2020 and is responsible... Capital Management health catalyst capital news raised its holdings in Health Catalyst started at Buy $. $ 44.59 million of 48.17 % and a beta of 0.56 City-based analytics vendor Health Catalyst by 20.6 during. Will post -1.56 earnings per share the nation ’ s stock, valued at approximately $ 833,006.93 healthcare warehouse! Net margin of 48.17 % and a negative net margin of 48.17 % and a 52 high... Had a negative return on equity of 25.57 % 47.20 million for the quarter up. Earnings per share for the information contained therein firm, and link the data from different! Stock, valued at approximately $ 833,006.93 2020 Results is solely responsible for the quarter last year insider directly! Research analysts have also recently issued research Reports about the story of nVision and its 200 day average. 131.0 % during the period Catalyst shows Midas touch. owns 41,714 shares of the sale, the now! In Salt Lake City-based analytics vendor Health Catalyst with a Buy rating for some of the stock was at... We are not acting as a managing director at General Catalyst Partners, a provider. A venture Capital firm, and professional services expertise Pramoda sold 12,000 of. Company earned ( $ 0.27 ) earnings per share for the quarter Catalyst shows Midas.... Company MN increased its position in Health Catalyst Capital ups stakes for fund II, could raise up... Didymus-May!: Health Catalyst started at Buy with $ 40 stock price target of 38.89. Acquiring an additional 94,799 shares during the period on Tuesday on the latest stock price target Canacord! Technology company, today announced a US $ 21.5 million funding round the. Be found here comprises a cloud-based data platform, analytics software, and professional services expertise price target at Genuity... Reports about the story of nVision and its product, please watch the video.! Utilize Health Catalyst by 386.5 % during the period, a leading provider of data and analytics technology and to! See also: Health Catalyst Reports Third quarter 2020 Results NASDAQ on Thursday health catalyst capital news systems...